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Key points
 Tenascin X (TNX) functions in the extracellular matrix of skin and joints where it maintains
correct intercellular connections and tissue architecture
 TNX is associated exclusively with vagal-afferent endings and some myenteric neurones in
mouse and human stomach, respectively.
 TNX-deficient mice have accelerated gastric emptying and hypersensitivity of gastric vagal
mechanoreceptors that can be normalized by an inhibitor of vagal-afferent sensitivity.
 Cultured nodose ganglion neurones showed no changes in response to capsaicin,
cholecystokinin and potassium chloride in TNX-deficient mice.
 TNX-deficient patients have upper gastric dysfunction consistent with those in amousemodel.
Our translational studies suggest that abnormal gastric sensory functionmay explain the upper
gut symptoms present in TNX deficient patients, thus making it important to study gastric
physiology.
 TNX deficiency should be evaluated routinely in patients with connective tissue abnormalities,
which will enable a better understanding of its role and allow targeted treatment. For example,
inhibitors of vagal afferents-baclofen could be beneficial in patients. These hypotheses need
confirmation via targeted clinical trials.
Abstract Tenascin-X (TNX) is a glycoprotein that regulates tissue structure via anti-adhesive
interactions with collagen in the extracellular matrix. TNX deficiency causes a phenotype similar
to hypermobility Ehlers–Danlos syndrome involving joint hypermobility, skin hyperelasticity,
pain and gastrointestinal dysfunction. Previously, we have shown that TNX is required for neural
control of the bowel by a specific subtype of mainly cholinergic enteric neurones and regulates
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sprouting and sensitivity of nociceptive sensory endings in mouse colon. These findings correlate
with symptoms shown by TNX-deficient patients and mice. We aimed to identify whether TNX
is similarly present in neural structures found in mouse and human gastric tissue. We then
determined whether TNX has a functional role, specifically in gastric motor and sensory function
and nodose ganglia neurones. We report that TNX was present in calretinin-immunoreactive
extrinsic nerve endings in mouse and human stomach. TNX deficient mice had accelerated
gastric emptying and markedly increased vagal afferent responses to gastric distension that could
be rescued with GABAB receptor agonist. There were no changes in nodose ganglia excitability
in TNX deficient mice, suggesting that vagal afferent responses are probably the result of altered
peripheral mechanosensitivity. In TNXB-deficient patients, significantly greater symptoms of
reflux, indigestion and abdominal pain were reported. In the present study, we report the first
role for TNX in gastric function. Further studies are required in TNX deficient patients to
determine whether symptoms can be relieved using GABAB agonists.
(Received 9 October 2018; accepted after revision 19 December 2018; first published online 14 January 2019)
CorrespondingauthorR.Aktar:Wingate Institute, 26Ashfield Street, LondonE1 2AJ,UK. Email: r.aktar@qmul.ac.uk
Introduction
Tenascin-X (TNX) is an extracellular matrix glycoprotein
belonging to a family of tenascins and other molecules
that governs tissue structure (Valcourt et al. 2015). Its
absence leads to heritable connective tissue disorders
with a phenotype similar to hypermobility Ehlers–Danlos
Syndrome (hEDS) (Zweers et al. 2004), although TNX
deficient patients are now classified as a separate sub-
group (Malfait et al. 2017). We recently showed that TNX
is expressed not only in connective tissue, but also in
colonic intrinsic neurones, and that it is required for
normal neural control of colonic motility (Aktar et al.
2018). Our data suggested a direct role in cholinergic
control, although we also found that absence of TNX
leads to hypertrophy and hypersensitivity of nociceptive
sensory nerve endings in the colon that do not themselves
express TNX, therefore suggesting an indirect role in pain.
These observations in knockout (KO) mice correlated
closely with gastrointestinal (GI) symptoms in genetically
confirmed TNX-deficient patients with hEDS, including
disruptedmotility and bowel habit, as well as visceral pain
(Aktar et al. 2018). There remains, however, a large gap
in our understanding because patients with hEDS suffer
from symptoms that are localized in both upper and
lower GI tract. The most common upper GI symptoms
include bloating, reflux, disordered gastric emptying of a
meal, nausea and indigestion (Castori et al. 2010; Mathias
et al. 2012; Fikree et al. 2014). We aimed to investigate
first whether there was a systematic link between TNX
gene deficiency and symptoms in humans and, second,
what is the underlying mechanism. In particular, vagal
afferent fibres innervating the upper GO tract play a
critical role both in initiation of symptoms and reflexes
controlling several functions (Page & Blackshaw, 2009),
Vagal afferents are comprised of two main types: (i)
mucosal endings that respond to touch and to chemical
stimuli and (ii) muscular endings that respond optimally
to mechanical stretch or tension (Page et al. 2002)
These gastric mechanoreceptors have been anatomically
identified as intraganglionic laminar endings (IGLE).
Another population of intramuscular arrays (IMA) may
also play a role in mechanosensation (Zagorodnyuk et al.
2001). They project to the brain stem where they provide
input to central sensory pathways andmotor programmes
(Browning & Travagli, 2010).
We first investigated the correlation between TNX
gene deficiency and symptom severity in a hEDS
patient cohort. We then determined TNX expression
in calretinin-immunoreactive structures analogous with
vagal afferent endings in both humans and mice.
Electrophysiological recordings were used to demonstrate
whether TNX KO mice have altered sensitivity of vagal
afferents to gastric distension. The association of changes
in vagal afferent function with overall gastrointestinal
function was explored by measuring gastric emptying
in vivo. We also investigated a means of normalizing
afferent function by activation of inhibitory GABAB
receptors on gastric vagal afferents. What emerges is
an inhibitory role for TNX in a specific population of
upper GI mechanosensory neurones, which may under-
lie fundamental aspects of sensory signal transduction
at afferent endings. Our findings further indicate that
these endings may be therapeutic targets for a range of
symptoms in patients with TNX deficiency and may have
a role in other patients such as those with hEDS.
Methods
Ethical approval
Full-thickness gastric tissue (non-pathological) was
obtained from cancer patients (>10 cm away from
tumors) undergoing gastrectomy using approved Human
C© 2019 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Research Ethics from Bart’s and London NHS Trust with
informed consent (NREC 09/H0704/2). Unfortunately,
we could not obtain tissue from TNX deficient patients;
however, TNX deficient patients gave theur written
informed consent prior to completing questionnaires.
All studies were completed in accordance with the
animal ethics policy and the study is in compliance the
ethical principles required by The Journal of Physiology
(Grundy, 2015). All mice used in these studies were killed
by asphyxiation using carbon dioxide in accordance with
theUKHomeOffice (Schedule 1, Animals Act 1986) for all
experimental procedures.All humanquestionnaire studies
were not registered in a database in accordance with the
Declaration of Helsinki.
Mouse tissue
Mice used in the present study originated from parent
mice with a C57BL/6N background and was donated
by Professor Manuel Koch (University of Cologne,
Cologne, Germany). The generation of these mice has
been described previously (Mao et al. 2002; Aktar et al.
2018). Knockout (KO) and wild-type (WT) mice were
phenotypically healthy, grew similarly and were of similar
weight at the time of the study (WT: 19.9 ± 0.8 g; KO:
20.8 ± 1.1 g). All mice were reared and transported
under conditions specified in theUK’s AnimalWelfare Act
2006. Mice aged between 10 and 12 weeks were used and
were killed by a rising concentration of CO2 asphyxiation
(Schedule 1, Animals Act 1986, U.K. Home Office).
Immunohistochemistry
Immunolabelling with rabbit polyclonal TNX (dilution
1:200, sc-25717, Santa Cruz Biotechnology, Santa
Cruz, CA, USA), calretinin (dilution 1:500, CG1
and 6B3, Swant, Mountain View, CA, USA) and
calcitonin gene-related peptide CGRP (dilution 1:400,
ab36001, Abcam, Cambridge, MA, USA; dilution 1:400;
ABS026-05-02; Thermo Fisher, Waltham, MA, USA) was
assessed in human and mouse specific stomach regions.
Additionally, choline acetyl transferase (ChAT) (dilution
1:400, ab18736, Abcam) was used in brainstem sections.
Immunohistochemistry process. Tissue was fixed in
4% paraformaldehyde in 10 μm sections and then
wholemounts were prepared and blocked in universal
blocking serum (Dako, Glostrup, Denmark), followed by
incubation overnight at 4°C with primary antibodies.
Slides/whole mount tissue was then incubated for 1 h at
room temperature with AlexaFluor conjugated secondary
antibody (Invitrogen, Carlsbad, CA, USA) as appropriate.
Slides/whole mounts were then mounted using a
coverslip and Vectashield Hardset Mountant (Vector
Laboratories, Inc., Burlingame,CA,USA) conjugatedwith
4′,6-diamidino-2-phenylindole (H-1500) and left to dry
before viewing under the microscope at 40×.
Vagal afferent recording studies
The methodology used was modified from Page et al.
(2002) because whole stomach was used. Once a
distension-sensitive fibre was identified, 1 mL of Krebs
solutionwas infused via a cannula into themouse stomach
for 1 min. After 1 min, the cannula was removed and
the stomach was allowed to drain naturally. The empty
stomach was then allowed to rest for 5 min before
repeating this process two more times. Separate TNX-KO
mice were used for baclofen studies, where, after two
distension recordings, baclofen (100μM) was infused into
the organ bath, as well as injected directly into the bath.
After 10 min of baclofen infusion, two further distensions
were made with a 5 min rest inbetween to measure the
effects of baclofen on afferent firing. Gastric compliance
was measured using a pressure transducer, which was
attached to the cannula and used to infuse the stomach
with standard volumes of Krebs solution. Single units
were discriminated using wavemark analysis via Spike2
(Cambridge Electronic Design Ltd, Cambridge, UK).
Gastric emptying studies
Mice were fasted overnight, placed in separate chambers,
then consumed an egg yolk meal containing 1 μL 1 g–1
C13 octanoic acid (99% enrichment; Cambridge Iso-
tope Laboratories, Andover, MA, USA). Once fully
consumed, breath samples were collected at intervals
up to 150 min and analysed for 13CO2/12CO2 using
the isotope-ratio mass spectrometer (Thermo Finnigan,
Dreieich, Germany). Excretion data were analysed using
non-linear regression analysis for curve fitting to obtain
gastric emptying half-life (t½) and time taken for solid
digestion into the duodenum (Tlag) (Ghoos et al. 1993).
Primary cell culture and calcium imaging of nodose
ganglia
Primary cell cultures from the nodose ganglia of
12-week-old WT and TNX-KO mice were prepared. Both
nodose ganglia were removed under a stereomicroscope
and placed immediately in cold F12 complete nutrient
medium. The ganglia were dissociated by enzymatic
digestion in two steps. First by collagenase II and dispase
3 mg mL–1 in Hank’s balanced salt solution (HBSS) with
agitation at 5 min intervals over 30 min and then by
collagenase II alone for 15 min. After incubation, the
ganglia were rinsed in cold HBSS and F12 and further
dissociated by trituration using a fine pipette. Cells were
C© 2019 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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then pelleted, rinsed in HBSS and resuspended in Neuro-
Basal Amedium(ThermoFisher). The cells were plated on
poly-D-lysine coated 24-well plates andplaced in a 5%CO2
incubator at 37°C for 2 h to allow cell adherence. After 2 h,
warmed complete NeuroBasal A medium (supplemented
with B-27, penicillin/streptomycin and glutamax) was
added to each well and incubated for 48 h before the
experiments. After 2 days of incubation, cell cultures were
loaded with Fluo-4-AM to detect calcium flux 1 h before
rinsing the cells with Krebs and reloading with Krebs.
Changes in intracellular Ca2+ concentration [Ca2+] are
reflected by the Fluo-4-AM fluorescence intensity and
were recorded at 525/50 nm. Baseline activity of identified
neurones was recorded for 120 s and then stimulated with
either capsaicin (100 nM), cholecystokinin (CCK) (10 nM)
or KCl (50 mM) for 120 s. Images were acquired every
5 s with a confocal LSM 880 with Airyscan using Zen
software (Carl Zeiss, Oberkochen, Germany). Changes
in flourescence intensity were measured by drawing a
region of interest around neurones, and then measuring
the change in fluorescence intensity. The total number of
neurones that responded to stimuli was then averaged over
a single time point. Peak intensity within the first 10 s was
measured in cell cultures from both mouse groups. An
identified neurone that changed in intensity as a result
of the stimuli was described as a responder, whereas a
non-responder was described as neurone that showed no
changes in fluorescence intensity. The total number of
neurones that responded to capsaicin, CCK and KCl was
noted individually. We sampled nodose ganglia neurones
randomly to determine whether TNX deficient neurones
respond differently as a population; more subtle changes
maybe revealed using patch clamp recordings fromneuro-
nes retrogradely labelled from the stomach.
Patient genotyping
Eleven patients (three males and eight females) identified
from Radboud University Medical Centre took part and
were genotyped for TNXB (Schalkwijk et al. 2001).
Mutation analysis was performed using next-generation
sequencing testing TNXB DNA mutation, as described
previously (Demirdas et al. 2016). Additionally, serum
samples were analysed for TNX glycoprotein using
an enzyme-linked immunosorbent assay with rabbit
anti-TNX.
GI symptom questionnaire
Patients with TNXdeficiency completed a Flemish version
of the validated Gastrointestinal Symptom Rating Scale
(GSRS) (Svedlund et al. 1988). Questionnaire responses
were translated and scored for five different domains:
reflux, abdominal pain, constipation, indigestion and
diarrhoea. Scores ranged from 1 (no symptoms) to 7
(unbearable symptoms). GSRS scores for abdominal pain
and upper GI symptoms for reflux and indigestion were
analysed in TNX deficient patients in comparison with
a reference Swedish population of similar age and sex
(Dimenas et al. 1996).
Experimental design and statistical analysis
Immunohistochemistry. Qualitative images were ob-
tained for both human and mouse stomach. Controls
with no primary antibody were performed with each run
of immunohistochemistry to confirm the specificity of the
primary antibody, which resulted in no fluorescence above
background.
A western blot with this antibody in humans revealed
a band at the predicted weight of 268 kDa. Moreover
TNX was absent in all TNX-KO gut tissue. Images were
obtained using Metamorph software (Molecular Devices,
Sunnyvale, CA, USA) on an Olympus (Tokyo, Japan)MM
Leica (Wetzlar, Germany) (sections) or Zen software on
a LSM 710 or LSM 880 (Carl Zeiss) (confocal imaging
wholemounts) at 40× magnification.
Vagal afferent recordings. In total, 12 WT and 12 KO
mice (six females and six males in both groups) were
used to measure spontaneous and post distension afferent
activity in the stomach. Separate baclofen experiments in
four WT vs. four KO mice (two females and two males in
both groups) were also performed. Data were statistically
analysed with an unpaired t test and individual data were
plotted for all data sets with P < 0.05 being considered
statistically significant.
Gastric emptying. In total, nine WT vs. 15 KO mice (five
females and fourmales inWT and seven females and eight
males in KO) were used. Statistical analysis was performed
with an unpaired t test to compare betweenmouse groups
and individual data were plotted with P < 0.05 being
considered statistically significant.
Calcium imaging. In total, fiveWT vs. five KOmice (three
females and two males in both groups) were used. In
total, 25 WT and 17 KO individual nodose neurones were
stimulated with KCL and capsaicin, respectively, whereas
18 WT and 34 KO individual nodose neurones were
stimulated with CCK. Statistical analysis was performed
using an unpaired t test. Individual data were plotted and
P < 0.05 was considered statistically significant.
Patient questionnaires. In total, 11 patients (three males
and eight females) with TNX deficiency were used and
comparedwith a reference Swedishpopulation (n=2162).
The reason for the small sample size in TNX deficient
C© 2019 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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group is the small number of patients known to have
TNX deficiency because it is uncommonly measured.
Questionnaire data are shownas themean± SD. Statistical
analysis was performed using an unpaired Student’s t test
for each symptom, with P < 0.05 being considered
statistically significant.
All data are expressed as individual data points and
variability within the data was represented using 95%
confidence intervals of the mean. Statistical analysis was
performed using Prism, version 7.02 (GraphPad Software
Inc., San Diego, CA, USA).
Results
TNX localization in mouse and human stomach
Calretinin-immunoreactivity is a well-established marker
for vagal afferents in rodent upper gut, and reliably labels
IGLE and IMA (Berthoud et al. 1995; Fox et al. 2000;
Phillips & Powley, 2000; Powley et al. 2013). In the mouse
stomach, fibres positive for TNX+ calretinin were seen
in circular muscle (Fig. 1B). Fibres in stomach showed
partially overlapping immunoreactivity for calretinin
and TNX and corresponded anatomically and neuro-
chemically to IMA (Fig. 1B) and IGLE (Berthoud &
Neuhuber, 2000). TNX and calretinin-immunoreactive
colocalization was also observed surrounding myenteric
ganglia in IGLEs (Fig. 1A), which have been previously
described as tension-sensitive vagal afferents (Berthoud
& Powley, 1992; Phillips & Powley, 2000; Zagorodnyuk
et al. 2001). Correspondingly, TNX-immunoreactivity
was found in a subpopulation of cell bodies of vagal
afferent neurones in the nodose ganglia (Fig. 1C)
and more centrally in punctate endings within the
nucleus tractus solitarius, with some in close proximity
to dendrites of TNX-negative ChAT-positive neuro-
nes (presumably vagal preganglionic motorneurones)
in the adjacent dorsal motor nucleus of the vagus
(Fig. 1D). Peripherally, qualitative analysis shows that
some TNX-immunoreactive cell bodies were present in
gastric myenteric ganglia of human fundus (Fig. 1E) but
not in mouse (Fig. 1A). CGRP did not co-label with TNX
in human fundus (Fig. 1F). Similar to the mouse circular
muscle, TNX-immunoractive IMA were also found in
human smooth muscle (Fig. 1G).
Gastric vagal afferent sensitivity in mice
The pattern of TNX localization in calretinin-
immunoreactive endings in the stomach suggested a role
in vagal afferent (IGLE and IMA) function; therefore, we
investigated whether there was an alteration in mechano-
sensory and electrophysiological properties of gastric vagal
afferents that lack TNX. Single afferent fibre recordings
of gastric tension receptors that are mechanosensitive to
contraction and distension exhibiting slow adaptation to
innocuous wall tension (Page et al. 2002) were analysed.
Spontaneous firing was significantly increased by 66%
in TNX-KO compared to WT (0.23 ± 0.06 WT vs.
0.69± 0.08KO, P= 0.0003) (Fig. 2C). Similarly, responses
to distension were significantly increased in TNX-KO
(2.37 ± 0.67 WT vs. 9.67 ± 1.2 KO, P < 0.0001)
(Fig. 2D). Distension-induced changes in intragastric
pressure showed no difference in the area under curve
(1598.9 ± 168.2 WT vs. 2055.6 ± 177.9 KO, P = 0.7326)
(Fig. 2E). Therefore, gastric compliance is unaltered,
suggesting increased afferent sensitivity in TNX-KO is
a property of the afferent neurones and not their
environment.
Rescue of afferent hypersensitivity in TNX-KO mice
Addition of the GABAB receptor agonist baclofen caused
a significant reduction in spontaneous firing (0.69 ± 0.08
KO vs. 0.13 ± 0.029 KO + baclofen, P < 0.0001)
(Fig. 2C) and afferent firing during distension in TNX-KO
(9.67±1.2KO vs.1.55±0.253KO+baclofen,P<0.0001)
(Fig. 2D). Afferent firing post baclofen was reduced in
TNX-KO mice similar to levels observed in WT mice
(Fig. 2C).
Gastric emptying
Because vagal afferents showed mechanical hyper-
sensitivity in the absence of TNX, we investigated whether
translated to reflex control of gastric motility by observing
gastric emptying in TNX-KO. In WT, a gradual increase
in labelled CO2 ultimately peaked at 90 min, whereas
TNX-KOmice had a rapid increase that peaked at 60 min
(Fig. 3A). Starting at 100 min, CO2 gradually declined
in WT mice, unlike TNX-KO that had a rapid decline at
75 min, demonstrating faster gastric emptying (Fig. 3A).
The t½ (158 min ± 21.8 WT vs. 103 min ± 12.9 KO,
P = 0.0277) (Fig. 3B) and tlag (24 min ± 2.7 WT vs.
38 min ± 5.7 KO, P = 0.0194) (Fig. 3C) were significantly
reduced in TNX-KO, suggesting that propulsive motility
of the stomach is enhanced.
Excitability of cultured nodose ganglia
Vagal afferent hypersensitivity could be the result of an
altered generation of action potentials by mechanical
stimuli at the endings or by altered excitability of the
neurone as a whole. To determine which is most probable,
nodose ganglia neurones were isolated from their target
and studied in culture. They grew similarly (Fig. 4A) in
both WT and KO mice, indicating a lack of influence
of TNX on cytoarchitecture and viability. Responsiveness
was assessed by peak calcium responses within the first
C© 2019 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 1. TNX is expressed in neural structures in the stomach
Representative immunohistochemical images taken from whole mount mouse fundus labelled with TNX and
calretinin in IGLE surrounding the MP but not in cell bodies (A). TNX-immunoreactivity was commonly found in
calretinin-immunoreactive fibres in the smooth muscle layer of the stomach (B, merge). The cell bodies of vagal
C© 2019 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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afferents in the nodose ganglia also showed positive TNX and calretinin co-labelling in sections (C, merge). TNX
positive endings found in the mouse nuclus tractus solitarius (NTS) (D). Unlike mouse, human fundus sections
showed TNX- and calretinin-immunoreactive cell bodies in the myenteric plexus (MP) (E, merge) that were distinct
from CGRP fibres (F, merge). TNX also co-labelled calretinin-positive endings in the circular smooth muscle (G,
merge). All images from mouse and human stomach are whole mount confocal z-images except for nodose
ganglia (NG) and circular muscle (CM) images, which were taken with an epifluorescence microscope. DMN,
dorsal motor nucleus. Scale bars in (A–D) = 25 μm, (E–G) = 30.
10 s post-KCl, CCK and capsaicin, which showed no
differences between WT or TNX-KO neurones (Fig. 4B).
Additionally, there were no differences in the number
of responders vs. non-responders to KCl, CCK and
capsaicin between groups (Fig. 4C). Thus, the changes
that we observed are most probably a result of mechanical
hypersensitivity.
Gastrointestinal symptoms in TNX deficient patients
TNX deficient patients showed significantly increased
severity of GI symptoms overall (P< 0.0001) compared to
healthy controls (Fig. 5). Specifically, symptoms of gastro-
esophageal reflux, abdominal pain and indigestion were
all increased significantly.
Figure 2. Vagal afferent mechanosensitivity in WT and TNX-KO mice
Responses to distension from single vagal afferent units innervating the stomach in WT vs. KO. Nerve discharge
rate (histogram) was increased in KO in both spontaneous and distended (1 mL of fluid in stomach) conditions (A).
B, corresponding raw trace to the nerve discharge rate. Spontaneous (C) (P = 0.0003) and distension (P < 0.0001)
induced afferent firing (D) was significantly increased in TNX-KO compared to WT, (n = 14 WT afferent units vs.
n = 18 KO afferent units). Addition of baclofen (100 μM) significantly reduced both spontaneous (P < 0.0001)
and distension (P < 0.0001) induced firing back to levels similar to those observed in WT mice (C and D) (n = 23
KO afferent units). Baclofen also reduced WT spontaneous (P < 0.0001) and distension (P = 0.028) induced firing
(C and D) (n = 22 WT afferent units). There was no change in gastric compliance to 1 mL of Krebs over 1 min in
WT vs. TNX-KO mice (n = 12 WT vs. n = 12 KO). E, statistical analysis was performed using an unpaired t test.
C© 2019 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Discussion
Having recently discovered a novel role for TNX in enteric
neurones of the lower GI tract, it followed that there
was probably also a role in the upper gut, particularly
in view of the fact that patients with TNX deficiency have
both upper and lower GI symptoms. We found a strong
correlation between TNX gene deficiency and upper GI
symptom severity in a patient cohort. Correspondingly,
TNX was normally present in calretinin-immunoreactive
structures, analogous to vagal afferent endings in both
humans andmice. Electrophysiological recordings showed
that TNX KO mice have greatly enhanced sensitivity of
vagal afferents to gastric distension. This is associated
with accelerated gastric emptying in vivo, and matches
the upper GI symptoms reported by patients. We also
show that increased afferent function can be reversed by
activation of inhibitory GABAB receptors on gastric vagal
afferents. Thus, TNX plays an inhibitory role in a specific
population of upper GI mechanosensory neurones, and
may underlie aspects of sensory signal transduction at
afferent endings. Our findings further indicate these end-
ings may be therapeutic targets for a range of symptoms
in patients with TNX deficiency and may have a role in
other patients such as those with hEDS.
TNX-immunoreactivity was found in a small
population of nodose ganglion neurones and in sparse
central vagal terminals in the nuclus tractus solitarius.
Therefore, we corroborated our finding in hindgut
indicating that TNX is expressed byGI neurones, although
with the exception that expression in upper gut occurs in
extrinsic, rather than intrinsic neurones. This indicates
a very different role for TNX in the upper GI tract.
TNX-immunoreactivity was seen often in endings that
colocalized with calretinin. It is established from other
work that these are vagal afferent terminalswith cell bodies
in the nodose ganglia (Berthoud et al. 1995; Fox et al. 2000;
Phillips & Powley, 2000; Powley et al. 2013), which fits
with the lackofTNX-immunoreactive intrinsic cell bodies.
Correspondingly, based on this finding of TNX expression
in extrinsic neurones, it was important to determine
whether TNX influences vagal afferent function, which
we investigated with a gastric vagal afferent preparation
adapted from those used prevously (Page et al. 2002) to
reveal differences between genotypes.We observed greater
mechanosensitivity and baseline discharge of individual
low-threshold distension-sensitive afferents, known as
tension receptors (Page et al. 2002). This was in the
absence of changes in gastric compliance, suggesting that
it was a property of the nerve endings only. This notion
was further supported by studies of nodose ganglion cell
bodies, which showed no difference in responsiveness
after application of KCl, CCK or capsaicin. This leads
us to assume that TNX plays a specialized role in the
anchoring of nerve terminals to their targets, perhaps by
allowing flexibility between the two. Thus, without TNX,
the afferent ending becomes less dynamic in its attachment
and reaches fullmechanical distortionwith lessmovement
Figure 3. Gastric emptying in WT and
TNX-KO mice
13CO2 excretion curve in WT vs. KO. KO curve
(grey) showing an increase in gastric emptying
rate because the curve has shifted to the left
(A). The half-life (t½) was significantly reduced
in the KO (103 ± 12.9 min; P = 0.0277). B,
time taken for solid food to be broken down
(tlag) was significantly reduced in the KO
(24 min ± 2.7; P = 0.0194) (C) (n = 9 WT vs.
n = 15 KO). Statistical analysis was performed
using an unpaired t test.
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relative to the surrounding tissue. As shown in Fig. 6,
the spacing of mechanosensory terminals and smooth
muscle elements is critical for normal afferent signalling.
It will require further studies with electron microscopy
to determine whether this anchoring role is tenable. In
our previous study of high threshold nociceptive colonic
afferents in the splanchnic nerves (Aktar et al. 2018), we
also found increased mechanosensitivity in the TNX-KO,
although TNX labelling was not associated with the end-
ings themselves and was mutually exclusive with their
marker: CGRP. In that case, there was 50% greater
mechanosensitivity in the KO, whereas, in the present
study, we found a 400% greatermechanosensitivity, which
is perhaps not unexpected given the direct association of
TNXwith vagal afferents compared to the distinct location
of TNX relative to splanchnic afferents. This is by far the
biggest difference in vagal function that we have seen in
several comparisons of KOs of sensory genes with WTs,
suggesting that the role of TNX is critical. The indirect role
of TNX in splanchnic afferents is supported by the fact that
they appeared to sprout into the otherwise TNX-negative
mucosa (Aktar et al. 2018) (suggesting a barrier function),
whereas their direct role in vagal afferents is supported
by the observation that their anatomical relation to other
tissues was not noticeably altered in TNX-KO, although
their function was markedly different.
Figure 4. Capsaicin and CCK effects in cultured nodose neurones
Differential interference contrast image of neurones in culture, at baseline and stimulated neurone (A). The average
peak intensity within the first 10 s shows no change in response to KCl, capsaicin or CCK (B). Numbers of responsive
and non-responsive neurones show no change in WT and KO with KCl, capsaicin or CCK stimulation (C) (n = 25
WT vs. n = 17 KO for KCL/capsaicin experiments and n = 18 WT vs. n = 34 KO for CCK experiments).
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The main expected consequence in vivo of increased
gastric vagal afferent sensitivity, upon reaching the central
nervous system (CNS) would be increased perception
of non-nociceptive mechanical forces in the stomach,
although mouse models are not available for this.
Therefore, we investigated another major consequence of
vagal afferent activation, which is the control of gastric
emptying (Browning et al. 2014). This is mediated via
a vago-vagal reflex in the brainstem, where we saw
localization of TNX presumably at the central endings
Figure 5. Gastrointestinal symptoms in TNX deficient patients
and healthy controls
The severity of gastrointestinal symptoms assessed using the GSRS
scores (means and 95% confidence interval) in patients with TNX
deficiency (n = 11) and healthy controls (n = 2162). Abdominal
pain, reflux and indigestion were significantly higher in TNX deficient
patients compared to Swedish controls (∗∗∗∗P < 0.0001). Statistical
analysis was performed using a two-way ANOVA (Sidak multiple
comparison test).
of vagal afferents. It is known that distension of the
proximal stomach promotes motor activity of the distal
stomach via this reflex, which serves to augment the antral
pump, in turn facilitating the emptying of solids from
the stomach through the pylorus into the duodenum
(Grundy et al. 1989), (Andrews et al. 1980). There was
a faster rate of gastric emptying of a solid meal in
TNX-KO that was comparable to the greater afferent
sensitivity, which supports a role for TNX in this pathway
in vivo. Although studies of gastric emptying specifically
in TNX-deficient patients are lacking, some studies of
emptying in ungenotyped hEDS patients show increased
solid emptying (Menys et al. 2017), suggesting the same
phenomenon. By comparison of GSRS questionnaire
data, we were able to determine whether TNX-deficient
patients reported upper GI symptoms differently from to
controls, and we found that, in cases of the perception of
indigestion and reflux, scores were approximately double
in the TNX-deficient cohort compared to controls. This
is in addition to the lower GI symptoms that we already
reported in this cohort.
The data would suggest that all upper GI symptoms
in TNX-deficient patients (and possibly therefore those
reported in a large number of hEDS patients) may
have a common origin in the hypersensitivity of vagal
afferents. In that case, it would make these endings a
potential therapeutic target. This has been suggested pre-
viously,when the triggeringof transient lower oesophageal
sphincter relaxations by vagal afferents via a similar
pathway was exploited as a therapeutic target for
gastro-oesophageal reflux disease (Tonini et al. 2004).
Figure 6. Hypothesized anti-adhesive mechanisms by which TNX supports sensory function
In the stomach, vagal afferent endings are maintained at an optimal attitude to the host tissue by TNX, whether
that be ganglia or muscle, or possibly interstitial cells (not shown). Without TNX, the ECM is improperly supported
and so excessive strain, both resting and particularly active, is exerted on the mechanosensitive elements of the
afferent ending.
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Specifically, the expression of GABAB receptors by vagal
afferents was exploited as a means of reducing their
excitability, and thus the strength of their signal to
the central motor programme giving rise to sphincter
opening that allows acid reflux (Zhang et al. 2002).
This was carried out almost successfully in clinical trials,
despite the lack of any evidence for hypersensitivity of
vagal afferents in gastro-oesophageal reflux disease. In
the present study, however, we have a demonstrable
hypersensitivity that is specific to mechanical stimuli,
which we know is susceptible to inhibition via GABAB
receptors. Therefore, we aimed to rescue the hyper-
sensitivity of vagal afferents using the prototypic GABAB
receptor agonist baclofen. This was highly effective,
with profound inhibition of responses to distension, as
well as spontaneous activity. Unfortunately, baclofen has
considerable effects on theCNS(Dario et al.2007) and so it
was not possible to determinewhether these effects seen in
the organ bath were translatable to in vivo experiments on
gastric emptying. For that, a more peripherally restricted
compound would be required.
Generally speaking, mouse and human data were
comparable in the present study in terms of differences
between TNX-deficient and control cohorts. However,
not all parameters could be assessed, such as gastric
emptying in TNX-deficient patients (for ethical reasons
related to their primary referral) and upper GI symptoms
in mice (because of lack of outcome markers). In the
case of TNX localization, we were able to compare
directly the two species and we did find discrepancy. The
mouse lacked completely any somatic labelling in gastric
myenteric neurones for TNX, whereas human specimens
invariably showed that gastric myenteric neurones were
TNX-immunoreactive, albeit at a much lower abundance
than those in the lower GI tract. This may suggest
that the neuronal subtypes may differ between species
and, indeed, it has been noted previously that very few
or no after-hyperpolarization (AH)/Type II myenteric
neurones are found in the upper GI tract of some
species but not others (Mazzuoli & Schemann, 2012).
Of importance is the observation that larger mammals
more probably possess these neurones, which means
that TNX-immunoreactivity may be serving as a marker
for this population, along with calretinin (although not
exclusively). This would fit with the far higher prevalence
of TNX + calretinin-immunoreactive enteric neurones
in the colon, where AH/Type II neurones are common in
all species. It was not possible to observe fine anatomical
detail of the neurones labelled in the present study, and
therefore their Dogiel type, although the colocalization of
TNX with calretinin is a further indicator that this is their
phenotype. Intrinsic AH/Type II neurones more closely
resemble extrinsic sensory neurones than other functional
subtypes in the enteric nervous system, and so it may be
that TNX associates exclusively with a non-nociceptive
sensory phenotype because vagal afferents are also sensory
neurones.
Perineuronal nets (PNN) are a feature of central
synapses, and are formed by the interaction of another
tenascin, tenascin-R, with various extracellular matrix
(ECM)components (Sorg et al.2016). PNNare involved in
structural connections between neurones and in synaptic
plasticity (Kwok et al. 2011). We have no indications from
our data as to whether or not TNX fulfils such a role in
the gut or in the dorsal vagal complex because labelling of
other ECM components is required to do this definitively.
However, it is intriguing how IGLE form a basket-like
network around myenteric ganglia, which may serve a
structural role in the delineation of discrete ganglia in
the enteric nervous system. The location and orientation
of IGLE and IMA would simultaneously assist in their
mechanosensory function by detecting force impinging
between and within smooth muscle layers.
Could differences in afferent endings lacking TNX
reflect a role for TNX in correct spacing of afferent
terminals relative to host tissue? By comparison, the
ECM molecule agrin is considered to be important
in forming neuromuscular junctions and maintaining
synapses between cholinergic preganglionic axons and
sympathetic neurons (Gingras et al. 2002). Mice lacking
a part of the agrin molecule show marked reduction in
acetylcholine receptor, which indicates that this molecule
is crucial in normal synapse function in the CNS
(Gingras et al. 2002), (Gautam et al. 1996). Moreover,
agrin increases nicotinic transmission at the synapse by
modulating the space between the gap junction-mediated
electrical coupling (Martin et al. 2005). Similar to agrins,
TNX may have a role in modulating the vagal afferent
microenvironment by regulating the intercellular spaces
between the vagal afferent terminals and smooth muscle
or interstitial cells of Cajal. Therefore, TNX probably
plays a similar role to other ECM proteins with respect
to modulating neural connectivity. Perhaps TNX is
important in maintaining the shape of vagal afferent
endings; therefore, the absence of TNX may transduce
mechanical forces less dynamically. The morphology of
vagal afferent endings in the KO model was not altered
and therefore this needs to be explored further at the
ultrastructural level.
In TNX deficiency, in addition to extracellular
abnormalities, ion channels that detect mechanical
sensitivity may be altered, thus affecting the movement of
sodium influx initiating the action potential. This change
could then result in increased afferent firing observed
in the KO. Interestingly, TNR is shown to modulate the
activity of sodium channels that are involved in action
potential generation (Weber et al. 1999), in particular
cells containing β1 and β2 subunits (Xiao et al. 1999).
TNR deficient mice show no change in the distribution
of sodium channels, although action potentials recorded
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from optic nerves showed a significant decrease in
conduction velocity (Weber et al. 1999). Because TNX and
TNRarewithin the same family, the functional importance
of voltage-gated sodiumchannelsmaybe affected similarly
by their removal.
In conclusion, we propose that TNX serves at least
two important roles in gastrointestinal neural function, in
addition to its established role in the structure and rigidity
of somatic tissues. These are: (i) a positive influence on
cholinergic neurotransmission in intrinsic enteric neuro-
nes in the intestine and (ii) a negative influence on
mechanical coupling of vagal afferent endings in the
stomach. These apparently opposite effects may both
ensue from changes in ultrastructure.
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